Cite
HARVARD Citation
Karimi, M. et al. (2015). Efficacy of Deferasirox (Exjade®) in Modulation of Iron Overload in Patients with β-Thalassemia Intermedia. Hemoglobin. pp. 327-329. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Karimi, M. et al. (2015). Efficacy of Deferasirox (Exjade®) in Modulation of Iron Overload in Patients with β-Thalassemia Intermedia. Hemoglobin. pp. 327-329. [Online].